Literature DB >> 12834031

Role of testosterone in feminine sexuality.

R E Nappi1, S Detaddei, F Ferdeghini, B Brundu, A Sommacal, F Polatti.   

Abstract

Gonadal steroids play a crucial role in maintaining the anatomical and functional integrity of all the structures involved in feminine sexual response. While the role of estrogens on the activity of neuroendocrine circuitries and on the trophism of genital organs has been well established, the contribution of androgens to female physical and mental well-being is still a matter of debate. Recent studies reconsidered the sources, production rates, circulating concentrations and regulatory mechanism of the major androgen precursors and androgens in women throughout the reproductive life span, as well as the wide variety of actions at the target tissues. Collectively, these reports support the therapeutic use of androgens in women, mainly to cure sexual dysfunctions, one of the consequences of menopause.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834031

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  4 in total

1.  Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy.

Authors:  Melissa Dahir; Dianne Travers-Gustafson
Journal:  Sex Med       Date:  2014-04       Impact factor: 2.491

2.  Role of hormones in hypoactive sexual desire disorder and current treatment.

Authors:  Ahmed AlAwlaqi; Houda Amor; Mohamed E Hammadeh
Journal:  J Turk Ger Gynecol Assoc       Date:  2017-12-15

Review 3.  Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?

Authors:  Rocco S Calabrò; Alberto Cacciola; Daniele Bruschetta; Demetrio Milardi; Fabrizio Quattrini; Francesca Sciarrone; Gianluca la Rosa; Placido Bramanti; Giuseppe Anastasi
Journal:  Brain Behav       Date:  2019-09-30       Impact factor: 2.708

4.  Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction.

Authors:  S Cipriani; E Maseroli; V Di Stasi; I Scavello; T Todisco; G Rastrelli; M Fambrini; F Sorbi; F Petraglia; E A Jannini; M Maggi; L Vignozzi
Journal:  J Endocrinol Invest       Date:  2021-06-12       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.